, Tracking Stock Market Picks
Enter Symbol:
Pain Therapeutics (PTIE) [hlAlert]

down 57.21 %

Pain Therapeutics (PTIE) rated Buy with price target $12 by C.K. Cooper

Posted on: Friday,  Aug 17, 2012  8:25 AM ET by C.K. Cooper

C.K. Cooper rated Buy Pain Therapeutics (NASDAQ: PTIE) on 08/17/2012, when the stock price was $4.09. Since
then, Pain Therapeutics has lost 57.21% as of 09/25/2015's recent price of $1.75.
If you would have followed this C.K. Cooper's recommendation on PTIE, you would have lost 57.21% of your investment in 1134 days.

Pain Therapeutics is developing a new generation of opioid painkillers.Opioids are drugs derived from the poppy plant. The company uses technology to reformulate opioid drugs, such as morphine, into new painkillers with improved clinical benefits. The company has four opioid painkillers in Phase II clinical trials. The company believes its drugs offer enhanced pain relief, fewer adverse side effects and reduced tolerance and addiction compared to existing opioid painkillers.

C. K. Cooper & Company has for over a decade provided insightful research ideas and commentary. As the firm identifies focus industries it brings together an analytical team to provide unique vision and insight to select investment ideas. In addition, leveraging on the expertise of the firm, the Research Team can evaluate opportunities against a wide database of industry and competitive trends.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/17/2012 8:25 AM Buy
4.09 12.00
as of 12/31/2012
1 Week up  5.44 %
1 Month down  -14.77 %
3 Months down  -46.33 %
1 YTD down  -33.74 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy